Chicago Wealth Management Inc. Lowers Stake in CME Group Inc. (NASDAQ:CME)

Chicago Wealth Management Inc. reduced its position in CME Group Inc. (NASDAQ:CMEFree Report) by 16.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,088 shares of the financial services provider’s stock after selling 219 shares during the period. Chicago Wealth Management Inc.’s holdings in CME Group were worth $229,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CME. Norges Bank bought a new position in CME Group in the 4th quarter worth approximately $959,260,000. Capital Wealth Planning LLC purchased a new position in CME Group during the fourth quarter valued at $253,563,000. Capital World Investors increased its holdings in CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after acquiring an additional 1,172,575 shares during the last quarter. Morgan Stanley lifted its stake in CME Group by 31.5% in the 3rd quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider’s stock worth $972,863,000 after purchasing an additional 1,163,103 shares in the last quarter. Finally, AEGON ASSET MANAGEMENT UK Plc purchased a new stake in CME Group in the 4th quarter worth $113,772,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other CME Group news, Director Daniel R. Glickman sold 650 shares of the business’s stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the sale, the director now directly owns 14,008 shares of the company’s stock, valued at approximately $2,821,771.52. The transaction was disclosed in a filing with the SEC, which is available through this link. In other CME Group news, Director Daniel R. Glickman sold 650 shares of the company’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the sale, the director now directly owns 14,008 shares in the company, valued at approximately $2,821,771.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Hilda Harris Piell sold 7,140 shares of the firm’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total value of $1,501,899.00. Following the transaction, the insider now owns 29,256 shares in the company, valued at approximately $6,153,999.60. The disclosure for this sale can be found here. Insiders have sold 51,290 shares of company stock valued at $10,807,380 in the last 90 days. Company insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on CME shares. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $210.00 target price (down from $235.00) on shares of CME Group in a report on Friday, April 5th. Barclays upped their price objective on CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a report on Thursday, April 25th. Argus raised their target price on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, March 6th. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research note on Thursday, April 25th. Finally, Morgan Stanley boosted their target price on shares of CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 9th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $217.80.

Read Our Latest Stock Report on CME Group

CME Group Trading Up 0.1 %

Shares of NASDAQ:CME traded up $0.20 during trading hours on Tuesday, hitting $198.70. 1,670,283 shares of the company’s stock traded hands, compared to its average volume of 1,807,887. The firm has a market capitalization of $71.54 billion, a P/E ratio of 22.59, a price-to-earnings-growth ratio of 5.27 and a beta of 0.52. The business has a fifty day moving average price of $209.39 and a 200-day moving average price of $210.51. CME Group Inc. has a 1 year low of $177.04 and a 1 year high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. CME Group’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same period last year, the company earned $2.42 EPS. Equities analysts expect that CME Group Inc. will post 9.72 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th will be issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date of this dividend is Friday, June 7th. CME Group’s payout ratio is presently 52.33%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.